1. Essential roles of B cell subsets in the progression of MASLD and HCC
- Author
-
Nataliia Petriv, Huizhen Suo, Inga Hochnadel, Kai Timrott, Nina Bondarenko, Lavinia Neubert, Elena Reinhard, Nils Jedicke, Patrick Kaufhold, Carlos Alberto Guzmán, Ralf Lichtinghagen, Michael P. Manns, Heike Bantel, and Tetyana Yevsa more...
- Subjects
Metabolic dysfunction-associated steatotic liver disease ,Non-alcoholic fatty liver disease ,Hepatocellular carcinoma ,B cells ,B regulatory cells ,Memory B cells ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a significant cause of HCC. Current treatment options for HCC are very limited. Recent evidence highlights B cells as key drivers in MASLD progression toward HCC. However, it remains unclear whether multiple B cell populations or a distinct B cell subset regulates inflammatory responses during liver disease progression. The scope of this study was to define protumorigenic B cell subsets in MASLD and HCC. Methods: Multicolor flow cytometry, immunohistochemistry, and immunofluorescence analyses were performed to investigate B cell populations locally (in liver tissue) and systemically (in the blood) in mice with MASLD (n = 6) and HCC (n = 5–6). The results obtained in mice were also verified in patients with MASLD (n = 19) and HCC (n = 16). Results: Our study revealed an increase of two regulatory B cell (Breg) subsets, CD19+B220+CD5+CD1d+ (p more...
- Published
- 2024
- Full Text
- View/download PDF